Marshall Wace North America L.P. - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 48 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2021$932,000
-5.1%
25,1440.0%0.00%0.0%
Q2 2021$982,000
-62.6%
25,144
-59.3%
0.00%
-63.6%
Q1 2021$2,629,00061,7580.01%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$21,500,00016.53%
Velan Capital Investment Management LP 293,385$10,946,00011.10%
Paradigm Biocapital Advisors LP 667,417$24,901,0004.96%
RTW INVESTMENTS, LP 3,996,154$149,097,0003.85%
Rock Springs Capital Management LP 2,671,652$99,679,0002.90%
TANG CAPITAL MANAGEMENT LLC 385,600$14,387,0002.18%
Samsara BioCapital, LLC 160,963$6,006,0001.60%
Avidity Partners Management LP 1,350,000$50,369,0001.16%
Pier Capital, LLC 123,394$4,604,0000.78%
Omega Fund Management, LLC 51,535$1,923,0000.61%
View complete list of IMMUNOCORE HLDGS PLC shareholders